Cargando…
Development of an Abbreviated Symptom Score for the Neonatal Abstinence Syndrome
OBJECTIVE: We sought a shortened MOTHER NAS and Finnegan score that would retain comparable performance characteristics of the full instrument. STUDY DESIGN: Retrospective cohort RESULTS: 124,170 MOTHER NAS scores between August 2007 and May 2016 from 775 infants (≥ 36 weeks) were examined. Classifi...
Autores principales: | Chervoneva, I, Adeniyi-Jones, SC, Blanco, F, Kraft, WK |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319884/ https://www.ncbi.nlm.nih.gov/pubmed/32076111 http://dx.doi.org/10.1038/s41372-020-0606-4 |
Ejemplares similares
-
Polygenic Risk Scores and the Need for Pharmacotherapy in Neonatal Abstinence Syndrome
por: Bibi, Shawana, et al.
Publicado: (2023) -
Association of a Simplified Finnegan Neonatal Abstinence Scoring Tool With the Need for Pharmacologic Treatment for Neonatal Abstinence Syndrome
por: Devlin, Lori A., et al.
Publicado: (2020) -
The Genomics of Neonatal Abstinence Syndrome
por: Cole, F. Sessions, et al.
Publicado: (2017) -
Improving the Assessment of Neonatal Abstinence Syndrome (NAS)
por: Chin Foo, Claire A., et al.
Publicado: (2021) -
Review of the assessment and management of neonatal abstinence syndrome
por: Bagley, Sarah Mary, et al.
Publicado: (2014)